tirzepatide and hfpef for Heart Failure in Patients with Obesity SUMMIT: Tirzepatide a 'Huge Win'

Some women with polycystic ovary syndrome (PCOS) have reported improved menstrual regularity whilst taking GLP-1 medications, though this is likely related to weight loss and improved insulin sensitivity rather than a direct pharmacological effect on ovarian function

Testosterone is important for sexual desire and erectile function

The off period prevents GHRH receptor desensitization and allows the pituitary to reset

The Short Answer: Yes, Low Testoste

The non-selectivity is both MT-2's strength (diverse pharmacology) and its weakness (unpredictable multi-system effects and increased side effect burden)

Tirzepatide is only available as an injectable treatment right now